Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Calcified Tissue International|February 16, 2018
Bone Loss After Romosozumab/Denosumab: Effects of BisphosphonatesAnne M Horne, Borislav Mihov, Ian R ReidCalcified Tissue International|May 14, 2017
Bone Loss After Denosumab: Only Partial Protection with ZoledronateIan R Reid, Anne M Horne, Borislav Mihov, et al.Seminars in Arthritis and Rheumatism|June 17, 2021
Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysisChang-Nam Son, Sarah Stewart, Isabel Su, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 21, 2023
No Effect of NSAID Use on Efficacy of Zoledronate: A Post Hoc Analysis of a Randomized Trial in Osteopenic Older WomenIan R Reid, Anne M Horne, Borislav Mihov, et al.The Journal of Clinical Endocrinology and Metabolism|February 5, 2020
Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized TrialAndrew Grey, Anne Horne, Greg Gamble, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 29, 2021
Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5-Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open-Label Extension of a Randomized Controlled TrialAndrew Grey, Mark J Bolland, Anne Horne, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 13, 2017
Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trialAndrew Grey, Mark J Bolland, Anne Horne, et al.Calcified Tissue International|March 13, 2021
Effect of Zoledronate on Lower Respiratory Infections in Older Women: Secondary Analysis of a Randomized Controlled TrialIan R Reid, Anne M Horne, Borislav Mihov, et al.The Journal of Rheumatology|July 15, 2026
Do people with tophaceous gout require more allopurinol for good clinical outcomes? Analysis of two randomized controlled trials with allopurinol dose escalationLisa K Stamp, Anne Horne, Jill Drake, et al.Arthritis Care & Research|April 11, 2023
Impact of Television Depictions of Gout on Perceptions of Illness: A Randomized Controlled TrialRachel Murdoch, Borislav Mihov, Anne M Horne, et al.Pageof 4